A Phase II Trial Evaluating Atrasentan In Patients With Advanced Renal Cell Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 18 May 2018
At a glance
- Drugs Atrasentan (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 02 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Aug 2005 New trial record.